Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Somnus, S&N ENT Acquisitions Allow Gyrus To Market Sleep Apnea RF In U.S.

This article was originally published in The Gray Sheet

Executive Summary

Gyrus Group will leverage the 86-person direct sales force of Smith & Nephew's ENT division to market Somnus Medical Technologies' Somnoplasty radiofrequency surgical system in the U.S., following its May 4 proposal to acquire both entities.

You may also be interested in...



Gyrus’ Purchase Of ACMI Will Boost UK Firm’s Presence In Endoscopy Space

Gyrus Group's upcoming acquisition of urology endoscope manufacturer ACMI will strengthen its presence in the rapidly growing $1.1 bil. endoscopy market, according to the London firm

Gyrus’ Purchase Of ACMI Will Boost UK Firm’s Presence In Endoscopy Space

Gyrus Group's upcoming acquisition of urology endoscope manufacturer ACMI will strengthen its presence in the rapidly growing $1.1 bil. endoscopy market, according to the London firm

AbilityOne To Double Rehabilitation Sales To $200 Mil. With S&N Rehab Unit

Smith & Nephew will retain a 21.5% equity interest in AbilityOne, which acquired S&N's rehabilitation business for $123 mil. in a deal announced March 27

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014839

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel